RESUMO

BACKGROUND: Magnetic ring (MSA) implantation in the esophagus is an alternative surgical procedure to fundoplication for the treatment of gastroesophageal reflux disease. AIMS: The aim of this study was to analyse the effectiveness and safety of magnetic sphincter augmentation (MSA) in patients with gastroesophageal reflux disease (GERD). METHODS: A systematic literature review of articles on MSA was performed using the Medical Literature Analysis and Retrieval System Online (Medline) database between 2008 and 2021, following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A random-effect model was used to generate a pooled proportion with 95% confidence interval (CI) across all studies. RESULTS: A total of 22 studies comprising 4,663 patients with MSA were analysed. Mean follow-up was 27.3 (7-108) months. The weighted pooled proportion of symptom improvement and patient satisfaction were 93% (95%CI 83-98%) and 85% (95%CI 78-90%), respectively. The mean DeMeester score (pre-MSA: 34.6 vs. post-MSA: 8.9, p=0.03) and GERD-HRQL score (pre-MSA: 25.8 vs. post-MSA: 4.4, p<0.0001) improved significantly after MSA. The proportion of patients taking proton pump inhibitor (PPIs) decreased from 92.8 to 12.4% (p<0.0001). The weighted pooled proportions of dysphagia, endoscopic dilatation and gas-related symptoms were 18, 13, and 3%, respectively. Esophageal erosion occurred in 1% of patients, but its risk significantly increased for every year of MSA use (odds ratio - OR 1.40, 95%CI 1.11-1.77, p=0.004). Device removal was needed in 4% of patients. CONCLUSIONS: Although MSA is a very effective treatment modality for GERD, postoperative dysphagia is common and the risk of esophageal erosion increases over time. Further studies are needed to determine the long-term safety of MSA placement in patients with GERD.

Assuntos

RESUMO

Large hiatal hernias, besides being more prevalent in the elderly, have a different clinical presentation: less reflux, more mechanical symptoms, and a greater possibility of acute, life-threatening complications such as gastric volvulus, ischemia, and visceral mediastinal perforation. Thus, surgical indications are distinct from gastroesophageal reflux disease-related sliding hiatal hernias. Heartburn tends to be less intense, while symptoms of chest pain, cough, discomfort, and tiredness are reported more frequently. Complaints of vomiting and dysphagia may suggest the presence of associated gastric volvulus. Signs of iron deficiency and anemia are found. Surgical indication is still controversial and was previously based on high mortality reported in emergency surgeries for gastric volvulus. Postoperative mortality is especially related to three factors: body mass index above 35, age over 70 years, and the presence of comorbidities. Minimally invasive elective surgery should be offered to symptomatic individuals with good or reasonable performance status, regardless of age group. In asymptomatic and oligosymptomatic patients, besides obviously identifying the patient's desire, a case-by-case analysis of surgical risk factors such as age, obesity, and comorbidities should be taken into consideration. Attention should also be paid to situations with greater technical difficulty and risks of acute migration due to increased abdominal pressure (abdominoplasty, manual labor, spastic diseases). Technical alternatives such as partial fundoplication and anterior gastropexy can be considered. We emphasize the importance of performing surgical procedures in cases of large hiatal hernias in high-volume centers, with experienced surgeons.

Assuntos

RESUMO

ABSTRACT BACKGROUND: Magnetic ring (MSA) implantation in the esophagus is an alternative surgical procedure to fundoplication for the treatment of gastroesophageal reflux disease. AIMS: The aim of this study was to analyse the effectiveness and safety of magnetic sphincter augmentation (MSA) in patients with gastroesophageal reflux disease (GERD). METHODS: A systematic literature review of articles on MSA was performed using the Medical Literature Analysis and Retrieval System Online (Medline) database between 2008 and 2021, following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A random-effect model was used to generate a pooled proportion with 95% confidence interval (CI) across all studies. RESULTS: A total of 22 studies comprising 4,663 patients with MSA were analysed. Mean follow-up was 27.3 (7-108) months. The weighted pooled proportion of symptom improvement and patient satisfaction were 93% (95%CI 83-98%) and 85% (95%CI 78-90%), respectively. The mean DeMeester score (pre-MSA: 34.6 vs. post-MSA: 8.9, p=0.03) and GERD-HRQL score (pre-MSA: 25.8 vs. post-MSA: 4.4, p<0.0001) improved significantly after MSA. The proportion of patients taking proton pump inhibitor (PPIs) decreased from 92.8 to 12.4% (p<0.0001). The weighted pooled proportions of dysphagia, endoscopic dilatation and gas-related symptoms were 18, 13, and 3%, respectively. Esophageal erosion occurred in 1% of patients, but its risk significantly increased for every year of MSA use (odds ratio — OR 1.40, 95%CI 1.11-1.77, p=0.004). Device removal was needed in 4% of patients. CONCLUSIONS: Although MSA is a very effective treatment modality for GERD, postoperative dysphagia is common and the risk of esophageal erosion increases over time. Further studies are needed to determine the long-term safety of MSA placement in patients with GERD.

RESUMO RACIONAL: A implantação de anel magnético (AM) no esôfago é um procedimento cirúrgico alternativo à fundoplicatulra, para o tratamento da doença do refluxo gastroesofágico. OBJETIVOS: O objetivo deste estudo foi analisar a eficácia e segurança do anel magnético em pacientes com doença do refluxo gastroesofágico (DRGE). MÉTODOS: Uma revisão sistemática da literatura de artigos sobre AM foi realizada usando o banco de dados Medline entre 2008 e 2021, seguindo as diretrizes PRISMA. Um modelo de efeito aleatório foi usado para gerar uma proporção agrupada com intervalo de confiança (IC) de 95% em todos os estudos. RESULTADOS: Um total de 22 estudos compreendendo 4.663 pacientes submetidos à colocação do AM foram analisados. O seguimento médio foi de 27,3 (7-108) meses. A proporção ponderada de melhora dos sintomas e satisfação do paciente foi de 93% (IC95% 83-98%) e 85% (IC95% 78-90%), respectivamente. A pontuação média de DeMeester (pré-AM: 34,6 versus pós-AM: 8,9, p=0,03) e pontuação GERD-HRQL (pré-AM: 25,8 versus pós-AM: 4,4, p<0,0001) melhoraram significativamente após a colocação do anel. A proporção de pacientes em uso de inbidor de bomba de prótons (IBP) diminuiu de 92,8% para 12,4% (p<0,0001). A erosão esofágica ocorreu em 1% dos pacientes, o risco aumentou significativamente para cada ano de uso do AM (OR 1,40; IC95% 1,11-1,77, p=0,004). A remoção do dispositivo foi necessária em 4% dos pacientes. CONCLUSÕES: O AM é uma modalidade de tratamento eficaz para a DRGE. A disfagia pós-operatória é comum, e o risco de erosão esofágica aumenta com o tempo.

Assuntos

RESUMO

METHODS: Gastroesophageal reflux disease is usually associated with esophageal or typical symptoms such as heartburn, regurgitation, and dysphagia. However, there is today mounting evidence that gastroesophageal reflux can also cause extra-esophageal or atypical problems such as cough, aspiration pneumonia, and pulmonary fibrosis. AIM: The aim of this study was to discuss the pathophysiology of extra-esophageal symptoms, the diagnostic evaluation, complications, and the outcome of video laparoscopic antireflux surgery. This study analyzes the recent literature review. RESULTS: It is important to separate patients with respiratory symptoms into two different groups: group I: patients having typical symptoms such as heartburn and respiratory symptoms, and group II: patients having respiratory symptoms only, in whom reflux is otherwise silent. CONCLUSIONS: Gastroesophageal reflux can cause respiratory symptoms in addition to esophageal typical symptoms. High index of suspicion should be present, and a complete workup was done to diagnose whether pathologic reflux is present and whether it extends to the proximal esophagus or pharynx. Antireflux surgery in these patients should be considered, as it is safe and effective.

OBJETIVO: A doença do refluxo gastroesofágico geralmente está associada a sintomas esofágicos ou típicos, como azia, regurgitação e disfagia. No entanto, existem hoje evidências crescentes, que o refluxo gastroesofágico também pode causar problemas extraesofágicos ou atípicos, como tosse, pneumonia por aspiração e fibrose pulmonar. discutir a fisiopatologia dos sintomas extraesofágicos, avaliação diagnóstica, complicações e o resultado da cirurgia videolaparoscópica antirrefluxo. MÉTODOS: Análise de revisão recente da literatura. RESULTADOS: É importante separar os pacientes com sintomas respiratórios em dois grupos distintos: grupo I: pacientes que apresentam sintomas típicos como azia e sintomas respiratórios e grupo II: pacientes que apresentam apenas sintomas respiratórios, nos quais o refluxo é silencioso. CONCLUSÕES: O refluxo gastroesofágico pode causar sintomas respiratórios além dos sintomas esofágicos típicos. Elevado índice de suspeita deve estar presente e uma avaliação completa deve ser feita para diagnosticar se o refluxo patológico está presente e se ele se estende ao esôfago proximal ou faringe. A cirurgia anti-refluxo nesses pacientes deve ser considerada, pois é segura e eficaz.

Assuntos

RESUMO

INTRODUCTION: Obesity may lead to hyperandrogenia and affect female sexual function. The study aims to evaluate female sexual function and androgenic profile in obese women after laparoscopic Roux-en-Y gastric bypass (LRYGB). METHODS: Forty obese women with a mean age of 34 years were prospectively studied. Diabetes and psychiatric and pelvic disorders were the exclusion criteria. All patients underwent LRYGB. Total (TT) and free (FT) testosterone, androstenedione (AD), dehydroepiandrosterone (DHEA) and the Sexual Quotient - Female Version were evaluated, preoperatively, 6 and 12 months after the operation. RESULTS: Preoperative incidence of sexual dysfunction was 10% and hyperandrogenia was 40%. At 6 months, sexual function was not different; and FT (0.49-0.33 ng/dl) and AD (2.0-1.3 ng/dl) decreased significantly. At 12 months, there was an improvement in female sexual function (77-84 points), related to desire and interest (22-25 points) and comfort (15.9-17.3 points) without case of sexual dysfunction at 12 months. Hyperandrogenia (40-8%), FT levels (0.5-0.3 ng/dl), and AD (2.0-1.4 ng/dl) decreased, while DHEA levels (3.4-4.2 ng/dl) increased. The percentage of weight loss was 22% and 31% at 6 and 12 months, respectively. Sexual function did not correlate with BMI, weight, or androgen levels in any period. CONCLUSION: Female sexual function in obese women with no diabetes and psychiatric and pelvic disorders improved in patients undergoing LRYGB, especially in desire, interest, and sexual comfort, and this occured after 6 months of the operation and unrelated to BMI, percentage of weight loss, or androgen levels. KEY POINTS: • In obese women with no diabetes and psychiatric and pelvic disorders the FSD improvement after LRYGB. • FSD no correlation with weight loss and BMI. • FSD no correlation with androgens levels.

Assuntos

Assuntos

RESUMO

RESUMO - RACIONAL: A doença do refluxo gastroesofágico geralmente está associada a sintomas esofágicos ou típicos, como azia, regurgitação e disfagia. No entanto, existem hoje evidências crescentes, que o refluxo gastroesofágico também pode causar problemas extraesofágicos ou atípicos, como tosse, pneumonia por aspiração e fibrose pulmonar. OBJETIVO: discutir a fisiopatologia dos sintomas extraesofágicos, avaliação diagnóstica, complicações e o resultado da cirurgia videolaparoscópica antirrefluxo. MÉTODOS: Análise de revisão recente da literatura. RESULTADOS: É importante separar os pacientes com sintomas respiratórios em dois grupos distintos: grupo I: pacientes que apresentam sintomas típicos como azia e sintomas respiratórios e grupo II: pacientes que apresentam apenas sintomas respiratórios, nos quais o refluxo é silencioso. CONCLUSÕES: O refluxo gastroesofágico pode causar sintomas respiratórios além dos sintomas esofágicos típicos. Elevado índice de suspeita deve estar presente e uma avaliação completa deve ser feita para diagnosticar se o refluxo patológico está presente e se ele se estende ao esôfago proximal ou faringe. A cirurgia anti-refluxo nesses pacientes deve ser considerada, pois é segura e eficaz.

ABSTRACT - BACKGROUND: Gastroesophageal reflux disease is usually associated with esophageal or typical symptoms such as heartburn, regurgitation, and dysphagia. However, there is today mounting evidence that gastroesophageal reflux can also cause extra-esophageal or atypical problems such as cough, aspiration pneumonia, and pulmonary fibrosis. AIM: The aim of this study was to discuss the pathophysiology of extra-esophageal symptoms, the diagnostic evaluation, complications, and the outcome of video laparoscopic antireflux surgery. METHODS: This study analyzes the recent literature review. RESULTS: It is important to separate patients with respiratory symptoms into two different groups: group I: patients having typical symptoms such as heartburn and respiratory symptoms, and group II: patients having respiratory symptoms only, in whom reflux is otherwise silent. CONCLUSIONS: Gastroesophageal reflux can cause respiratory symptoms in addition to esophageal typical symptoms. High index of suspicion should be present, and a complete workup was done to diagnose whether pathologic reflux is present and whether it extends to the proximal esophagus or pharynx. Antireflux surgery in these patients should be considered, as it is safe and effective.

Assuntos

Assuntos